Tevogen Inc.
TVGNW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001860871
No open-market purchases or sales by Tevogen Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $469.5K in total; no superinvestor holds it.
Other share classesTVGN
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Tevogen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Tevogen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Saadi Ryan H. | Chief Executive Officer | 11,705,689 | Sep 16, 2026 | 4 |
| Desai Kirti | Chief Financial Officer | 992,983 | Sep 16, 2026 | 3 |
| Goh Keow Lin | Director | 123,678 | Sep 15, 2026 | 2 |
| Podlogar Susan M | Director | 123,678 | Sep 15, 2026 | 2 |
| Sordillo Victor J. | Director | 126,539 | Sep 15, 2026 | 2 |
| Feike Jeffrey L. | Director | 131,435 | Sep 15, 2026 | 2 |
| Patton Curtis L. | Director | 139,192 | Sep 15, 2026 | 2 |
| Flomenberg Neal | See Remarks | 76,940 | Mar 17, 2026 | 1 |
| Khan Sadiq | Chief Commercial Officer | 1,169,618 | Jul 1, 2025 | 0 |
| Corbin Capital Partners, L.P. | 10% Owner | 0Indirect | Jul 18, 2023 | 0 |
| Corbin Capital Partners GP, LLC | 10% Owner | 0Indirect | Jul 18, 2023 | 0 |
| Corbin ERISA Opportunity Fund, Ltd. | 10% Owner | 0Indirect | Jul 18, 2023 | 0 |
| Ajjarapu Surendra K | CEO and Chairman | 8,988,889Indirect | Jun 21, 2023 | 0 |
| Semper Paratus Sponsor LLC | 10% Owner | 4,294,444 | Jun 8, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 (view filing) | Mar 10-13 | 7 daysLate | Flomenberg NealSee Remarks | SSale | −972 | $6.83 | −$6.64K | −1.2%76.9K after | 3 lots |
| Jun 9, 2025 (view filing) | Jun 9 | Same day | Saadi Ryan H.Chief Executive Officer | SSale | −1.44M | $1.23 | −$1.77M | −1.2%116.8M after | |
| Mar 14, 2025 (view filing) | Mar 12 | 2 days | Flomenberg NealSee Remarks | SSale | −233.0K | $1.09 | −$253.9K | −6.1%3.60M after | |
| Mar 11, 2025 (view filing) | Mar 7-11 | 4 days | Flomenberg NealSee Remarks | SSale | −211.9K | $1.09 | −$231.7K | −5.2%3.83M after | 3 lots |
| Mar 6, 2025 (view filing) | Mar 4-6 | 2 days | Flomenberg NealSee Remarks | SSale | −213.8K | $1.17 | −$250.0K | −5.0%4.04M after | 3 lots |
| Oct 18, 2024 (view filing) | Oct 17 | 1 day | Flomenberg NealSee Remarks | SSale | −1.08M | $1.62 | −$1.75M | −20.2%4.25M after | |
| Jun 13, 2024 (view filing) | Jun 12 | 1 day | Desai KirtiChief Financial Officer | PPurchase | +3.00K | $0.82 | +$2.46K | 0.0%9.70M after | |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Saadi Ryan H.Chief Executive Officer | PPurchase | +2.61K | $0.77 | +$2.01K | 0.0%118.3M after | |
| Jul 18, 2023 (view filing)5:36 PM ET | Jul 17 | 1 day | Corbin Capital Partners, L.P. and 2 others10% Owner | SSaleClass A Ordinary Shares, par value $0.0001 per share | −2.32M | $10.68 | −$24.8M | −100.0%0 after | 2 lots |
| Jun 8, 2023 (view filing) | Jun 7 | 1 day | Semper Paratus Sponsor LLC10% Owner | SSaleClass A Ordinary Shares, par value $0.0001 | −8.99M | $1.00 | −$8.99M | −67.7%4.29M after | |
| Nov 8, 2021 (view filing) | Nov 8 | Same day | Semper Paratus Sponsor LLC10% Owner | PPurchaseClass A Ordinary Shares, par value $0.0001 | +1.30M | – | – | New position1.30M after |